ArticleInternational journal of hematology2017

Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.

Mauro Di Ianni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.